In conclusion, our data support the hypothesis that somatic mutations in hematopoietic cells, specifically in the most commonly mutated CHIP driver genes TET2 and DNMT3A, may be significantly associated with the progression and poor prognosis of CHF of ischemic origin. The gene discussed is TET2; the disease is congestive heart failure.